06:10 EDT Aurinia Pharmaceuticals (AUPH) raises 2025 revenue view to $260M-$270M from $250M-$260M
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUPH:
- Aurinia Pharmaceuticals reports Q2 EPS 16c, consensus 15c
- Aurinia Pharmaceuticals Reports Strong Q2 2025 Financial Results and Expands Share Repurchase Plan
- Aurinia Pharmaceuticals assumed with a Buy at H.C. Wainwright
- Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results
- Aurinia Pharmaceuticals Reports Positive Phase 1 Results for Aritinercept